Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Interleukin-12 (IL-12) is a potent immunotherapeutic agent.

Bibliographic Details
Main Authors: Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S. Chard, Nicholas R. Lemoine, Yaohe Wang
Format: Article
Language:English
Published: Nature Publishing Group 2017-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-017-01385-8

Internet

https://doi.org/10.1038/s41467-017-01385-8

Similar Items